Lectins as anti-fibrotic agents

Details Lectins as anti-fibrotic agents Lectins as anti-fibrotic agents

2006-04-11

2006-04-11

Chism, B. Dell (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S387500, C530S395000, C424S725000

Reexamination Certificate

active

07026287

ABSTRACT:
The subject invention is directed to the treatment of tissue fibrosis by administration of an effective amount of lectin. Fibrosis herein refers to the accumulation of extracellular matrix constituents that occurs following trauma, inflammation, tissue repair, immunological reactions, cellular hyperplasia, and neoplasia. Examples of tissue fibrosis include, but are not limited to, pulmonary fibrosis, cirrhosis of the liver, skin scars and keloids, adhesions, fibromatosis, atherosclerosis, and amyloidosis. The treatment is intended for a variety of mammals, including humans.

REFERENCES:
patent: 2002/0001600 (2002-01-01), Oldham et al.
Gabolde et al., J. Med. Genet. 2001, vol. 38, pp. 310-311.
Garred et al. (Pediatric Pulmonology Mar. 2002, vol. 33, pp. 201-207.

Affiliated with

Also associated with

Rating

Lectins as anti-fibrotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lectins as anti-fibrotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lectins as anti-fibrotic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3529835